Hormone Use in Migraine with Aura: New Insights Unveiled

Research Summary

A recent study published in Pharmacoepidemiology and Drug Safety examines the use of oral contraceptives and hormone therapy among women with migraine with aura, a group traditionally advised against using combined oral contraceptives (COCs) due to stroke risk. Utilizing UK medical records from 2000 to 2024, the study found that 59% of reproductive-age women with migraine with aura used oral contraceptives post-diagnosis, favoring progestogen-only pills (POPs) over COCs. Among post-reproductive-age women, 45% used hormone therapy after diagnosis, with an increasing preference for transdermal formulations. The study highlights the need for robust evidence on stroke risk associated with these medications in this population.

Study Details

📄 Title: Utilization of Oral Contraceptives and Hormone Therapy for Menopause Among Female Individuals With Migraine With Aura: A Descriptive Study.

👥 Research Team: Gibbs LR et al.

📚 Published In: Pharmacoepidemiol Drug Saf

📅 Publication Date: 2025 Nov

⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.